Respiratory monitoring Market Size, Share, Industry, Forecast and outlook (2026-2033)

Global Respiratory Monitoring Devices Market is segmented By Product Type (Diagnostic devices (Spirometer, Peak Flow Meters), Monitoring Devices (Sleep Test Devices, Gas Analyzers, Pulse Oximeters, Capnography), By End-user (Hospitals, Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2026-2033

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy || SKU: MD1658

Report Summary
Table of Contents
List of Tables & Figures

Respiratory Monitoring Market Size

The global respiratory monitoring market was valued at USD 2.86 billion in 2025 and is projected to reach USD 6.02 billion by 2033, growing at a CAGR of 9.6 % during the forecast period from 2026 to 2033.

The market is witnessing strong growth driven by the rising prevalence of chronic respiratory diseases, increasing geriatric population, and growing demand for continuous patient monitoring solutions worldwide. Respiratory monitoring systems are gaining significant importance due to their ability to provide real-time assessment of respiratory rate, oxygen saturation, lung function, and overall pulmonary health, enabling early detection and effective management of respiratory conditions. Increasing incidence of asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, pneumonia, and other respiratory disorders is significantly contributing to the expansion of the respiratory monitoring market globally. In addition, rising adoption of remote patient monitoring, home healthcare solutions, and critical care technologies is creating strong growth opportunities across hospitals, ambulatory care centers, and homecare settings.

Respiratory monitoring devices closely monitor the respiration rate in individuals. These devices come as wearables, in-home settings, and in hospitals as systems. As respiration is the first sign of noticing any abnormality inside the body, monitoring respiratory rate is crucial in individuals suffering from heart ailments and other respiratory disorders.  

Respiratory Monitoring Market Scope

MetricsDetails
CAGR9.6%
Market Size Available for Years2023-2033
Estimation Forecast Period2026-2033
Revenue UnitsValue (US$ Mn) 
Segments CoveredProduct Type, End User
Regions CoveredNorth America, Europe, Asia-Pacific, South America, and Middle East & Africa
Largest RegionNorth America
Fastest Growing RegionAsia-Pacific
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

  For more details on this reportRequest for Sample

Market Dynamics: Drivers & Restraints

Increasing prevalence of respiratory diseases 

The increasing global burden of respiratory diseases like chronic obstructive pulmonary disorder, asthma, pneumonia, and others. For instance, according to the World Health Organization, COPD is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.

Due to increase in the tobacco smoking, respiratory diseases are rising. For instance, according to the Australian Institute of Health and Welfare, In 2021–22, there were 53,000 hospitalizations with a principal diagnosis of COPD for people aged 45 and over (500 hospitalizations per 100,000 population).

Furthermore, according to the American Lunch Association, In 2022, over 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.

Accuracy Concerns

Vital signs are monitored using respiratory monitoring devices which are read on the monitor provided. The accuracy of the device is important for any digital monitoring device. Some respiratory monitoring devices may face technical limitations that give rise to wrong results that impact further treatment. Technological advancements may limit the usage of the new devices compared to the traditional ones due to the lack of proper training and education.

Respiratory Monitoring Market Segment Analysis

The global respiratory monitoring market is segmented based on product type, end-user and region.

Pulse Oximeters Product Type is Expected to Dominate Market

Pulse Oximeters measure the oxygen in the blood. This non-invasive medical device is effective for monitoring respiratory functions. The launch of the products is expected to drive the market in the forecast period. For instance, in November 2023, BioIntelliSense launched a skin tone-sensitive pulse oximetry sensor as the FDA meets on racial bias. 

In April 2023, Masimo received FDA 510(k) clearance for its Rad-G with Temperature, a versatile handheld monitor that provides clinically proven SET pulse oximetry, respiration rate along other important parameters. 

In July 2023, Emerson launched the ASCO Series 588 Stationary Oxygen Concentrator Manifold, which reduces manufacturer engineering and assembly time and improves energy efficiency, product lifespan, and reliability of devices.

Respiratory Monitoring Market Geographical Analysis

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share of the market due to the increase in market developments that are actively taking place in the US. Due to the high prevalence of respiratory diseases in the North American region, the demand for respiratory monitoring devices is rising and companies are actively launching different products that monitor the respiratory rate in individuals. 

For instance, in February 2024, ResMed launched new bilevel sleep respiratory devices, AirCurve 11 series bilevel positive airway pressure devices in the U.S

Furthermore, in July 2023, ResMed, a leading medical device company acquired Somnoware, a US-based provider of sleep and respiratory care diagnostics software. The company aims to integrate Somnoware's products and services into its portfolio.

Key Developments

April 2026: Philips expanded advanced respiratory monitoring and connected patient care solutions across North America and Europe, strengthening its position in the global respiratory monitoring market and critical care technology sector.

February 2026: Medtronic launched AI-enabled respiratory monitoring systems and wearable breathing assessment devices across Asia-Pacific and the Middle East, supporting rising demand for remote patient monitoring and digital healthcare technologies.

December 2025: The United States accelerated adoption of continuous respiratory monitoring systems, ICU surveillance technologies, and telehealth respiratory care platforms, reinforcing growth in the regional critical care monitoring and healthcare digitization industry.

October 2025: GE HealthCare expanded cloud-based respiratory analytics and hospital monitoring platforms across Europe and North America, strengthening innovation in the patient surveillance and connected healthcare market.

September 2025: India increased investments in smart hospital infrastructure, respiratory diagnostic systems, and portable monitoring devices across major healthcare networks, supporting growth in the pulmonary care and medical device sector.

July 2025: Masimo introduced next-generation capnography and oxygen saturation monitoring technologies across global markets, accelerating expansion of the vital signs monitoring and respiratory diagnostics industry.

May 2025: Europe increased funding for telemedicine, AI-assisted respiratory diagnostics, and home healthcare monitoring systems across Germany, France, and the Netherlands, strengthening regional adoption of digital respiratory care and connected medical technologies.

March 2025: Dräger expanded ventilator-integrated respiratory monitoring and ICU patient management systems across Asia-Pacific and Europe, supporting innovation in the clinical monitoring and emergency healthcare market.

February 2025: China witnessed rising demand for wearable respiratory sensors, sleep apnea monitoring systems, and AI-powered pulmonary diagnostics, driving expansion of the domestic health monitoring and smart medical device industry.

January 2025: ResMed strengthened cloud-connected respiratory monitoring and sleep therapy technologies across North America and Australia, expanding innovation in the sleep monitoring and respiratory healthcare market.

Competitive Landscape

The major global players in the respiratory monitoring market include GE Healthcare, SMITH & NEPHEW, VYAIRE MEDICAL, INC., Masimo Corporation, Medtronic plc, Smiths Medical, COSMED, Nihon Kohden Corporation, Koninklijke Philips N.V., Novelda AS among others.

Why Purchase the Report?

  • To visualize the global respiratory monitoring market segmentation based on product type, disease type, route of administration, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of respiratory monitoring market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global respiratory monitoring market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

 

Save 31% on all licenses
Single User$4350$2999Multi User$4850$3344Corporate$7850$5412

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
PDF
DataM
Respiratory monitoring Market Report
SKU: MD1658

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports